Ciprofloxacin Actavis

Medicinal product

(Invented) name

Ciprofloxacin Actavis

Active substance (s)

Ciprofloksacinas

Strength

500 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J01MA02, Ciprofloxacin

Marketing authorisation holder

Teva B.V., Nyderlandai

Date of authorisation

2002-03-13

Date of renewal

2010-02-04

Documents

1848 Pakuotės lapelis 2025 04 08.docx

1848 Ciprofloxacin Actavis PCS PL 2025 04 08.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10a

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Ciprofloksacinas	500 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
3069	3607	1003607	lizdinė plokštelė	N10		Receptinis	LT/1/02/1848/001	Tiekiama	2025-05-09	-	No	-	-	Download

Stadijos

Data	Stadija
2010-02-04	Perregistruotas
2002-03-13	Registruotas